Stephan Polterauer

Associate Professor / MD

Medical University of Vienna

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Obstetrics And Gynecology

80%

Surgery

20%

Ovarian Cancer

90%

Oncology

40%

Gynecologic Oncology

40%

Cancer Biology

30%

Cancer Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles12

Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience

Article Link

Year:

2024

Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma

Article Link

Year:

2024

Krukenberg Progression of Gastric Carcinoma in Pregnancy: Is Early Diagnosis Possible? Case Report and Review of the Literature

Article Link

Year:

2023

Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial

Article Link

Year:

2023

Gestational and Non-gestational Trophoblastic Neoplasia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 032/049, April 2022)

Article Link

Year:

2023

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival

Article Link

Year:

2023

The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer

Article Link

Year:

2022

Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients

Article Link

Year:

2022

Real‐life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study ( <scp>RESPONSE</scp> trial)

Article Link

Year:

2022

Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters

Article Link

Year:

2022

Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial

Article Link

Year:

2022

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer

Article Link

Year:

2022

Collaborators7

Heini Lassus

University of Helsinki

FINLAND

Leonhard Müllauer

Pathologist/Molecular Pathologist/Associate Professor

Medical University of Vienna

AUSTRIA

Christoph Grimm

Medical University of Vienna

AUSTRIA

Sakari Hietanen

Chief of Dept.

Helsinki University Hospital

FINLAND

Ignacio Zapardiel

La Paz University Hospital

SPAIN

Renaud Sabatier

Associate Professor

Aix-Marseille Université Faculté de Medecine

FRANCE

Kinga Chalubinski

Medical University of Vienna

AUSTRIA

How do I reach out?

Meet Kite AI